LifeMD Q1 Revenue Surges Past Estimates on Record Telehealth Subscriber Growth
LFMD sits 80% above its 52-week low of $2.56.
Summary
LifeMD reported strong first-quarter results, with revenue reaching $50.2 million, comfortably beating analyst estimates of $48.84 million. The company also surpassed adjusted EBITDA expectations and achieved a record quarter for telehealth subscriber additions, ending Q1 with over 365,000 active subscribers. This performance was driven by significant momentum in weight management, which saw 120% sequential growth in new-patient revenues, and a substantial 657% quarter-over-quarter increase in women's health patient sign-ups. The expansion of gross margin to 88% further underscores improved operational efficiency. The company reaffirmed its full-year 2026 revenue guidance of $220 million to $230 million, signaling confidence in continued growth.
At the time of this announcement, LFMD was trading at $4.60 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $252.8M. The 52-week trading range was $2.56 to $15.84. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.